Brexafemme

Contamination Worries Prompt Scynexis to Recall Brexafemme, Putting Trials on Hold Following GSK’s Manufacturing Review

In a surprising development, Scynexis is taking a precautionary step to withdraw its antifungal medication, ibrexafungerp, marketed as Brexafemme, from ...